Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2026 16:30 ET | Source: TRG Latin America Acquisitions Corp.

TRG Latin America Acquisitions Corp. Announces Closing of Partial Exercise of IPO Over-Allotment Option

New York, NY, March 27, 2026 (GLOBE NEWSWIRE) -- TRG Latin America Acquisitions Corp. (the “Company”) (NASDAQ: TRGSU), announced today that the underwriter of its previously consummated initial...
March 27, 2026 16:30 ET | Source: Sotherly Hotels Inc.

Sotherly Hotels Inc. Announces Intention to List on OTC Market Platform, Voluntarily Delist from Nasdaq and Continue SEC Reporting

WILLIAMSBURG, Va., March 27, 2026 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (the “Company” or “Sotherly”), a real estate investment trust, announced today that its Board of Directors has approved the...
March 27, 2026 16:15 ET | Source: Aqua Metals

Aqua Metals to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Investor Conference Call on March 31, 2026

RENO, Nev., March 27, 2026 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in battery metals recycling and refining, today announced it will report financial results for the fourth...
March 27, 2026 16:15 ET | Source: Auddia Inc.

Auddia Announces Reverse Stock Split

Auddia Announces Reverse Stock Split
March 27, 2026 16:15 ET | Source: Crescent Biopharma, Inc.

Crescent Biopharma Announces Grants of Inducement Awards

WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the...
March 27, 2026 16:05 ET | Source: Entera Bio

Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with...
March 27, 2026 16:05 ET | Source: PMGC Holdings Inc.

NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments

NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in
March 27, 2026 16:05 ET | Source: SPAR Group, Inc.

SPAR Group, Inc. Announces Timing of Fiscal 2025 Fourth Quarter and Full Year Results Conference Call

CHARLOTTE, N.C., March 27, 2026 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR”, “SPAR Group” or the “Company”), an innovative services company offering comprehensive merchandising,...
March 27, 2026 16:05 ET | Source: Vera Therapeutics

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics announces inducement grants Under Nasdaq Listing Rule 5635(c)(4).
March 27, 2026 16:05 ET | Source: Cue Biopharma, Inc.

Cue Biopharma Announces CEO Transition

BOSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...